Livestreaming Platform Supported by:

custom image custom image custom image

  0       0

32nd Annual North American Cystic Fibrosis Conference


S22--NT-APP&D: Resolution of Inflammation in CF Airways: CFTR & Beyond


Oct 20, 2018 2:30pm ‐ Oct 20, 2018 3:55pm

Description

Airway disease remains the leading cause of morbidity and mortality in individuals with cystic fibrosis. The absence of CFTR leads to multiple changes in airways surface secretions and host defenses that are associated with severe and sustained airway inflammation. Correction of CFTR function may decrease part of the inflammatory process and prevent tissue destruction. However inflammation independent of CFTR is likely to persist. This symposium will address both CFTR -dependent and -independent mechanisms of resolving inflammation.

Learning Objectives:

  • Describe the impact of CFTR modulators on the host inflammatory response in cystic fibrosis.
  • Define the roles of macrophages and pro-resolving mediators in the CF airway inflammatory response.
  • Describe the results of a recently completed clinical trial of an anti-inflammatory drug in cystic fibrosis.

Symposium Chair(s):

Symposium Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content
token-speaker-name image
token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content